Trial Profile
An open-label study using the MedPulser electroporation system to treat cutaneous and subcutaneous foci of cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Oct 2017
Price :
$35
*
At a glance
- Drugs Bleomycin (Primary)
- Indications Skin cancer
- Focus Therapeutic Use
- Sponsors Inovio Pharmaceuticals
- 14 Jun 2007 New trial record.